As a BCS II drug, the atypical antipsychotic agent lurasidone
hydrochloride
(LH) has low oral bioavailability mainly because of its poor aqueous
solubility/dissolution. Unexpectedly, amorphous LH exhibited a much
lower dissolution than that of its stable crystalline form arising
from its gelation during the dissolution process. In the current study,
a supramolecular coamorphous system of LH with l-cysteine
hydrochloride (CYS) was prepared and characterized by powder X-ray
diffraction and differential scanning calorimetry. Surprisingly, in
comparison to crystalline and amorphous LH, such a coamorphous system
dramatically enhanced solubility (at least ∼50-fold in the
physiological pH range) and dissolution (∼1200-fold) of LH,
and exhibited superior physical stability under long-term storage
condition. More importantly, the coamorphous system was able to eliminate
gelation of amorphous LH during dissolution. In order to further explore
the mechanism of such improvement, the internal interactions of the
coamorphous system in the solid state and in aqueous solution were
investigated. Fourier transform infrared spectroscopy, Raman spectroscopy,
and solid-state 13C NMR suggested that intermolecular hydrogen
bonds formed between the nitrogen atom in the benzisothiazole ring
of LH and the NH3
+ group of CYS after coamorphization.
A fluorescence quenching test with a Stern–Volmer plot and
density functional theory modeling, phase-solubility study, and NMR
test in D2O indicated that ground-state complexation occurred
between LH and CYS in aqueous solution, which contributed to the solubility
and dissolution enhancement of LH. The current study offers a promising
strategy to overcome poor solubility/dissolution and be able to eliminate
gelation of amorphous materials by coamorphization and complexation.